Theravance Biopharma (TBPH) Interest & Investment Income (2014 - 2025)
Theravance Biopharma (TBPH) posted quarterly Interest & Investment Income of $42000.0 for Q3 2025, down 41.67% year-over-year from $72000.0 in Q3 2024, and up 520.0% quarter-over-quarter from -$10000.0 in Q2 2025.
Powered by 
Analysis
Theravance Biopharma (TBPH) Interest & Investment Income (2014 - 2025) Analysis & Trends
Theravance Biopharma (TBPH) has reported Interest & Investment Income for 12 consecutive years, with $42000.0 the latest figure, recorded in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.74 Bn | 130.89 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.52 Bn | 77.52 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.04 Bn | 52.91 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.46 Bn | 32.15 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Theravance Biopharma | 882.47 Mn | 494.82 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 42,000.00 |
| Jun 30, 2025 | -10,000.00 |
| Mar 31, 2025 | -7,000.00 |
| Sep 30, 2024 | 72,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Sep 30, 2023 | 61,000.00 |
| Jun 30, 2023 | -337,000.00 |
| Mar 31, 2023 | 66,000.00 |
| Sep 30, 2022 | -76,000.00 |
| Jun 30, 2022 | -17,000.00 |
| Mar 31, 2022 | -28,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | -9,000.00 |
| Mar 31, 2021 | -30,000.00 |
| Sep 30, 2020 | -158,000.00 |
| Jun 30, 2020 | -232,000.00 |
| Mar 31, 2020 | 367,000.00 |
| Sep 30, 2019 | -35,000.00 |
| Jun 30, 2019 | 165,000.00 |